老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

6.86
+0.0000
成交量：- -
成交额：- -
市值：4.32亿
市盈率：-7.79
高：6.86
开：6.86
低：6.86
收：6.86
数据加载中...
总览公司新闻公告
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/09/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/18

重要事件披露

8-K - Current report
2020/09/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/25

重要事件披露

8-K - Current report
2020/08/21

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/06/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/29

重要事件披露

8-K - Current report
2020/06/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/15

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/14

重要事件披露

8-K - Current report
2020/04/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership